Carcinoma
📧 Sign up to get email alerts when something new happens for Carcinoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2025-12-15Clinical Trial Update: Short-term Psychodynamic Psychotherapy in Serious Physical Illness [NA]
The study completed a trial evaluating short-term psychodynamic psychotherapy for individuals with cancer and other serious physical illness…
-
CLINICAL_TRIALS trial_result · 2025-12-09Clinical Trial Update: MAGE A10ᶜ⁷⁹⁶T for Advanced NSCLC [Phase 1]
A Phase 1 trial of Adaptimmune's MAGE-A10 796T T-cell receptor therapy for advanced non-small cell lung cancer has completed the Phase 1 sta…
-
CLINICAL_TRIALS trial_result · 2025-07-17Clinical Trial Update: Stereotactic MRI-guided Adaptive Radiation Therapy (SMART) in One Fraction [NA]
Clinical trial evaluating stereotactic MRI-guided adaptive radiation therapy (SMART) in one fraction for metastatic carcinoma has completed …
-
CLINICAL_TRIALS trial_result · 2025-04-10Clinical Trial Update: Trial Comparing Active Intervention At Diagnosis With Usual Care to Improve Psycho-social Care in AYAO [NA]
A completed clinical trial comparing an active psycho-social intervention at diagnosis with usual care to improve psychosocial support in AY…
-
CLINICAL_TRIALS trial_result · 2025-03-24Clinical Trial Update: First in Human Study With NG-641, a Tumour Selective Transgene Expressing Adenoviral Vector [Phase 1]
The first-in-human Phase 1 study of NG-641, a tumor-selective transgene-expressing adenoviral vector from Akamis Bio, has completed.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2025-01-17Clinical Trial Update: A Study to Evaluate the Diagnostic Efficacy of 68Ga- MY6349 PET/CT in Patients With Tumours [NA]
This clinical trial update notes a study evaluating the diagnostic efficacy of 68Ga-MY6349 PET/CT in patients with carcinomas (tumors of epi…
-
CLINICAL_TRIALS trial_result · 2025-01-03Clinical Trial Update: Immune Checkpoint Inhibitor and MR-guided SBRT for Limited Progressive Metastatic Carcinoma. [NA]
Terminated clinical trial evaluating the combination of an immune checkpoint inhibitor with MR-guided SBRT for limited progressive metastati…
-
CLINICAL_TRIALS trial_result · 2024-02-13Clinical Trial Update: Hormone Receptor Positive endometrIal Carcinoma Treated by Dual mTORC1/mTORC2 Inhibitor and Anastrozole (VICTORIA) [Phase 1, Phase 2]
Phase 1/2 trial investigating dual mTORC1/mTORC2 inhibitor with anastrozole for hormone receptor–positive endometrial carcinoma (metastatic)…
-
CLINICAL_TRIALS trial_result · 2024-02-07Clinical Trial Update: Evaluation Glizigen® and Ocoxin®-Viusid® in High-grade Cervical Intraepithelial Lesions [Phase 2]
Phase 2 clinical trial evaluation of Glizigen and Ocoxin-Viusid for high-grade cervical intraepithelial lesions is ongoing with an unknown s…
-
CLINICAL_TRIALS trial_result · 2023-07-13Clinical Trial Update: A Clinical Trial of KVA12123 Treatment Alone and in Combination With Pembrolizumab In Advanced Solid Tumors (VISTA-101) [Phase 1, Phase 2]
Clinical trial update for KVA12123 as a standalone and in combination with pembrolizumab in advanced solid tumors; current status is unknown…
-
CLINICAL_TRIALS trial_result · 2023-03-06Clinical Trial Update: Continuous Infusion of rhIL-15 for Adults With Advanced Cancer [Phase 1]
Phase 1 trial updating continuous infusion of rhIL-15 in adults with advanced cancer; completed with results posted.
-
CLINICAL_TRIALS trial_result · 2022-07-21Clinical Trial Update: Tislelizumab in Combination With Chemotherapy for Conversion Therapy of Locally Nonresectable ESCC [Phase 2]
Phase 2 trial evaluating tislelizumab with chemotherapy for conversion therapy in locally nonresectable esophageal squamous cell carcinoma.
-
CLINICAL_TRIALS trial_result · 2022-02-17Clinical Trial Update: PEN-866 in Patients With Advanced Solid Malignancies [Phase 1, Phase 2]
Clinical trial update for PEN-866 across multiple phases investigating advanced solid malignancies, including endometrial adenocarcinoma and…
-
CLINICAL_TRIALS trial_result · 2021-11-10Clinical Trial Update: ADC Combined With Hypofractionated Radiotherapy, PD-1/PD-L1 Sequential GM-CSF and IL-2 for Treatment of HER-2 Positive Advanced Solid Tumors(PRaG3.0) [Phase 2]
Phase 2 clinical trial evaluating ADC with hypofractionated radiotherapy followed by sequential PD-1/PD-L1 blockade with GM-CSF and IL-2 for…
-
CLINICAL_TRIALS trial_result · 2020-12-19Clinical Trial Update: Evaluation of Enzastaurin in the Treatment of Persistent or Recurrent Ovarian or Primary Peritoneal Cancer [Phase 2]
Phase 2 clinical trial evaluating enzastaurin for persistent or recurrent ovarian or primary peritoneal cancer has completed with results po…
-
CLINICAL_TRIALS trial_result · 2020-12-10Clinical Trial Update: A Study of Aflibercept Administered in Combination With Pemetrexed and Cisplatin in Participants With Advanced Carcinoma [Phase 1, Phase 2]
Clinical trial of aflibercept with pemetrexed and cisplatin in advanced carcinoma and non-small cell lung cancer was terminated; results pos…
-
CLINICAL_TRIALS trial_result · 2020-11-05Clinical Trial Update: Efficacy and Safety of Lanreotide Microparticles as Palliative Treatment in Peritoneal Carcinomatosis [Phase 3]
Phase 3 trial evaluating lanreotide microparticles for palliative treatment in peritoneal carcinomatosis; completed study assessing efficacy…
-
CLINICAL_TRIALS trial_result · 2019-12-13Clinical Trial Update: Study of Pembrolizumab (MK-3475) in Participants With Progressive Locally Advanced or Metastatic Carcinoma, Melanoma, or Non-small Cell Lung Carcinoma (P07990/MK-3475-001/KEYNOTE-001) [Phase 1]
Phase 1 study of pembrolizumab (MK-3475) in participants with progressive locally advanced/metastatic carcinoma, melanoma, or non-small cell…
-
CLINICAL_TRIALS trial_result · 2019-03-28Clinical Trial Update: Temozolomide in Preventing Brain Metastases in Small Cell Lung Cancer [Phase 2]
A Phase 2 clinical trial investigating temozolomide for preventing brain metastases in small cell lung cancer is reported as ongoing with un…
-
CLINICAL_TRIALS trial_result · 2018-05-23Clinical Trial Update: A Non Interventional Study With Irinotecan Onkovis (Irinotecan) Utilized for the Treatment of Cancer
A non-interventional study evaluating irinotecan (Onkovis) for treating cancer has completed.
-
CLINICAL_TRIALS trial_result · 2018-04-18Clinical Trial Update: A Study of Cixutumumab (IMC-A12) in Islet Cell Cancer [Phase 2]
Phase 2 clinical trial update for cixutumumab (IMC-A12) in islet cell cancer, with completed status and posted results.
-
CLINICAL_TRIALS trial_result · 2017-03-17Clinical Trial Update: CSP #562 - The VA Keratinocyte Carcinoma Chemoprevention Trial [Phase 4]
Phase 4 trial update for a keratinocyte carcinoma chemoprevention study (VA CSP #562) has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2015-06-04Clinical Trial Update: A Non Interventional Study With Doce Onkovis (Docetaxel) Utilized for the Treatment of Cancer
This completed non-interventional study evaluated the use of Docetaxel (Doce Onkovis) for the treatment of carcinoma.
-
CLINICAL_TRIALS trial_result · 2014-12-18Clinical Trial Update: Clinical Pharmacology Study of Brentuximab Vedotin (SGN-35) [Phase 1]
Phase 1 pharmacology study update of Brentuximab vedotin (SGN-35) has completed, according to clinical trials data. The study involves patie…
-
CLINICAL_TRIALS trial_result · 2014-09-11Clinical Trial Update: Phase I, Pharmacokinetic, Pharmacodynamic Trial of PTK787 and Paclitaxel in Combination for Advanced Solid Tumors [Phase 1]
Phase I pharmacokinetic/pharmacodynamic study evaluating the combination of PTK787 (Vatalanib) with Paclitaxel in patients with advanced sol…